If the next few years of obesity care are going to be defined by broader GLP-1 access, the question isnt just who gets the medication, its who gets the support to maximize outcomes and limit weight regain
This vital molecule plays a crucial role in protecting your body from cancer
3.3.1 Central immune system: aberrant activation of microglia and astrocytes In EDC, aberrant microglial and astrocytic activation constitutes a central mechanism linking neuroinflammation to neural circuit dysfunction
The disorder is characterized by seven biochemically distinct alterations, all resulting in the increase in concentrations of homocystine and methionine in body fluids (Table 1)
Practical result: Better visceral fat targeting during GLP-1 protocols, particularly in the later phases when the easy fat has already come off
Emerging 2026 recommendations suggest that protein requirements should be individualized and often increased during obesity treatment